A new approach for skin tumor treatment: From delivery system characterization to in vivo evaluation

Drug Delivery and Translational Research

Volumn 1, Issue 1, 2011, Pages 53-65

  Ainbinder, Denize ^a   Touitou, Elka ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cell differentiation; Delivery; Skin cancer; Sulfoxide; Topical; Tumor; Tumorep

Indexed keywords

CYTOKERATIN 14; DECYL METHYL SULFOXIDE; FLUOROURACIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL DIFFERENTIATION; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SAFETY; DRUG STABILITY; DRUG STORAGE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; SKIN PENETRATION; SKIN TEST; SKIN TUMOR; TUMOR REPRESSIVE DELIVERY SYSTEM;

EID: 84863005623     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-010-0006-y     Document Type: Article

References (20)

1. Ainbinder D, Touitou E. Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv. 2005; 12: 297-303.
2. Ainbinder D, Protokin R, Chaouat M, Touitou E. Effect of honokiol and 5-FU on non-melanoma skin cancer cells. J Drug Deliv Sci Tech. 2009; 19: 283-7.
3. Ben-Bassat H, Rosenbaum-Mitrani S, Hartzstark Z, et al. Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytes. Cancer Res. 1997; 57: 3741-50.
4. Bonnotte B, Gough M, Phan V, et al. Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cells. Cancer Res. 2003; 63: 2145-9.
5. Choi KH, Kim GM, Kim SY. The keratin-14 expression in actinic keratosis and squamous cell carcinoma: is this a prognostic factor for tumor progression? Cancer Res Treat. 2010; 42: 107-14.
6. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials. 2000; 21: 1879-85.
7. Dillaha J, Jansen GT, Honeycutt WM, et al. Selective cytotoxic effect of topical 5-fluorouracil. Arc Dermatol. 1983; 119: 774-83.
8. Fang JY, Lee WR, Shende SC, Huangaet YL. Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas. J Dermatol Sci. 2006; 42: 101-9.
9. Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release. 2004; 94: 365-79.
10. Jacobi U, Kaiser M, Toll R, et al. Porcine ear skin: an in vitro model for human skin. Skin Res Tech. 2007; 13: 19-24.
11. Kawamata H, Tachibana M, Fujimori T, Imai Y. Differentiation-inducing therapy for solid tumors. Curr Pharm Des. 2006; 12: 379-85.
12. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65: 55-63.
13. Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol. 2007; 4: 432-69.
14. Omer L, Ruthstein S, Goldfarb D, Talmon Y. High-resolution cryogenic-electron microscopy reveals details of a hexagonal-to-bicontinuous cubic phase transition in mesoporous silica synthesis. J Am Chem Soc. 2009; 131: 12466-73.
15. Reynolds PL, Strayer SM. Treatment of skin malignancies. J Fam Pract. 2003; 52: 456-64.
16. Romano RA, Birkaya B, Sinha S. A functional enhancer of keratin 14 is a direct transcriptional target of Np63. J Invest Dermatol. 2007; 127: 1175-86.
17. Rougier A, Dupuis D, Lotte C, Roguet R, Wester RC, Maibach HI. Regional variation in percutaneous absorption in man: measurement by the stripping method. Arch Dermatol Res. 1986; 278: 465-9.
18. Shumilov M, Touitou E. Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies. Int J Pharm. 2010; 387: 26-33.
19. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000; 65: 403-18.
20. Yoshimoto Y, Augustine CK, Yoo JS, et al. Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents. Mol Cancer Ther. 2007; 6: 1492-500.